Answers are grounded in this paper and cite their sources.
Organophosphate-induced delayed polyneuropathy (OPIDN) is a rare neurological complication of organophosphate poisoning that typically develops 1–4 weeks after exposure and may be overlooked after apparent recovery from the acute illness. Reports describing the sequential occurrence of acute cholinergic syndrome, intermediate syndrome, and OPIDN following acute chlorpyrifos poisoning are scarce, particularly in Ethiopia . We report the case of an 18-year-old Ethiopian woman who presented three hours after intentionally ingesting an unknown quantity of chlorpyrifos. She initially developed acute cholinergic toxicity requiring intensive care management with atropine. During hospitalization, she developed intermediate syndrome with respiratory muscle weakness requiring mechanical ventilation. Eighteen days after discharge, she presented with progressive bilateral lower-limb weakness, bilateral foot drop, and inability to walk independently. Neurological examination, nerve conduction studies, and needle electromyography demonstrated a predominantly motor axonal polyneuropathy, consistent with organophosphate-induced delayed polyneuropathy after exclusion of other potential causes. This case highlights the sequential progression of acute cholinergic syndrome, intermediate syndrome, and organophosphate-induced delayed polyneuropathy following acute chlorpyrifos poisoning. It underscores the importance of continued neurological surveillance after apparent clinical recovery and the value of electrophysiological studies in establishing the diagnosis of OPIDN, particularly in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Dhalbeny et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: